Literature DB >> 30344903

Potent Antimalarial Activity of Two Arenes Linked with Triamine Designed To Have Multiple Interactions with Heme.

Yosuke Sakata1, Kosuke Yabunaka1, Yuko Kobayashi1, Hirohisa Omiya1, Naoki Umezawa1, Hye-Sook Kim2, Yusuke Wataya2, Yoshimi Tomita1, Yosuke Hisamatsu1, Nobuki Kato1, Hirokazu Yagi1, Tadashi Satoh1, Koichi Kato1,3, Haruto Ishikawa4, Tsunehiko Higuchi1.   

Abstract

Based on the idea that compounds designed to exhibit high affinity for heme would block hemozoin formation, a critical heme-detoxification process for malarial parasites, we synthesized a series of compounds with two π-conjugated moieties at terminal amino groups of triamine. These compounds exhibited moderate to high antimalarial activities in vitro toward both chloroquine-sensitive and chloroquine-resistant Plasmodium falciparum. In a P. berghei-infected mouse model, 3a and 12a showed potent antimalarial activities compared to artesunate, as well as a prolonged duration of antimalarial effect. We found a good correlation between protective activity against hemin degradation and antimalarial activity. Compounds 8b and 3a strongly inhibited hemozoin formation catalyzed by heme detoxification protein.

Entities:  

Year:  2018        PMID: 30344903      PMCID: PMC6187406          DOI: 10.1021/acsmedchemlett.8b00222

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  36 in total

1.  Antiplasmodial activity and cytotoxicity of bis-, tris-, and tetraquinolines with linear or cyclic amino linkers.

Authors:  S Girault; P Grellier; A Berecibar; L Maes; P Lemière; E Mouray; E Davioud-Charvet; C Sergheraert
Journal:  J Med Chem       Date:  2001-05-24       Impact factor: 7.446

2.  Bisquinolines. 1. N,N-bis(7-chloroquinolin-4-yl)alkanediamines with potential against chloroquine-resistant malaria.

Authors:  J L Vennerstrom; W Y Ellis; A L Ager; S L Andersen; L Gerena; W K Milhous
Journal:  J Med Chem       Date:  1992-05-29       Impact factor: 7.446

Review 3.  Antimalarial drugs inhibiting hemozoin (beta-hematin) formation: a mechanistic update.

Authors:  Sanjay Kumar; Mithu Guha; Vinay Choubey; Pallab Maity; Uday Bandyopadhyay
Journal:  Life Sci       Date:  2006-11-10       Impact factor: 5.037

4.  Quinoline-pyrimidine hybrids: synthesis, antiplasmodial activity, SAR, and mode of action studies.

Authors:  Kamaljit Singh; Hardeep Kaur; Peter Smith; Carmen de Kock; Kelly Chibale; Jan Balzarini
Journal:  J Med Chem       Date:  2013-12-31       Impact factor: 7.446

5.  Protein complex directs hemoglobin-to-hemozoin formation in Plasmodium falciparum.

Authors:  Monika Chugh; Vidhya Sundararaman; Saravanan Kumar; Vanga S Reddy; Waseem A Siddiqui; Kenneth D Stuart; Pawan Malhotra
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-05       Impact factor: 11.205

6.  Deferoxamine: stimulation of hematin polymerization and antagonism of its inhibition by chloroquine.

Authors:  S R Vippagunta; A Dorn; A Bubendorf; R G Ridley; J L Vennerstrom
Journal:  Biochem Pharmacol       Date:  1999-09-01       Impact factor: 5.858

7.  Activity of piperaquine and other 4-aminoquinoline antiplasmodial drugs against chloroquine-sensitive and resistant blood-stages of Plasmodium falciparum. Role of beta-haematin inhibition and drug concentration in vacuolar water- and lipid-phases.

Authors:  David C Warhurst; John C Craig; Ipemida S Adagu; R Kiplin Guy; Peter B Madrid; Quinton L Fivelman
Journal:  Biochem Pharmacol       Date:  2007-03-19       Impact factor: 5.858

8.  Synthesis and activity of some antimalarial bisquinolines.

Authors:  K Raynes; D Galatis; A F Cowman; L Tilley; L W Deady
Journal:  J Med Chem       Date:  1995-01-06       Impact factor: 7.446

9.  HDP-a novel heme detoxification protein from the malaria parasite.

Authors:  Dewal Jani; Rana Nagarkatti; Wandy Beatty; Ross Angel; Carla Slebodnick; John Andersen; Sanjai Kumar; Dharmendar Rathore
Journal:  PLoS Pathog       Date:  2008-04-25       Impact factor: 6.823

10.  In Vivo and In Vitro Activities and ADME-Tox Profile of a Quinolizidine-Modified 4-Aminoquinoline: A Potent Anti-P. falciparum and Anti-P. vivax Blood-Stage Antimalarial.

Authors:  Nicoletta Basilico; Silvia Parapini; Anna Sparatore; Sergio Romeo; Paola Misiano; Livia Vivas; Vanessa Yardley; Simon L Croft; Annette Habluetzel; Leonardo Lucantoni; Laurent Renia; Bruce Russell; Rossarin Suwanarusk; Francois Nosten; Giulio Dondio; Chiara Bigogno; Daniela Jabes; Donatella Taramelli
Journal:  Molecules       Date:  2017-12-01       Impact factor: 4.411

View more
  3 in total

1.  Functionalized Naphthalimide-4-aminoquinoline Conjugates as Promising Antiplasmodials, with Mechanistic Insights.

Authors:  Jenny Legac; Adebayo A Adeniyi; Prishani Kisten; Philip J Rosenthal; Parvesh Singh; Vipan Kumar
Journal:  ACS Med Chem Lett       Date:  2020-01-08       Impact factor: 4.345

2.  Synthesis and in silico ADME/Tox profiling studies of heterocyclic hybrids based on chloroquine scaffolds with potential antimalarial activity.

Authors:  Hegira Ramírez; Esteban Fernandez-Moreira; Juan R Rodrigues; Michael R Mijares; Jorge E Ángel; Jaime E Charris
Journal:  Parasitol Res       Date:  2021-11-15       Impact factor: 2.289

3.  Design, synthesis, heme binding and density functional theory studies of isoindoline-dione-4-aminoquinolines as potential antiplasmodials.

Authors:  Anu Rani; Sumit Kumar; Jenny Legac; Adebayo A Adeniyi; Paul Awolade; Parvesh Singh; Philip J Rosenthal; Vipan Kumar
Journal:  Future Med Chem       Date:  2019-12-05       Impact factor: 3.808

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.